English NmVac4-A/C/Y/W-135 Cited by user Waddie96 on 22 Sep 2019 NmVac4-A/C/Y/W-135 is the commercial name of the polysaccharide vaccine against the bacteria (specifically serogroups A, C, Y, and W-135) that causes Meningococcal…
English NmVac4-A/C/Y/W-135 Cited by user Davidruben on 15 Feb 2009 The methods of manufacture of the vaccine product is now patented in the United States (USPTO) and in the WIPO Patent Cooperation Treaty (PCT) countries.